How to screen non-viral gene delivery systems in vitro?

Screening of new gene delivery candidates regarding transfection efficiency and toxicity is usually performed by reading out transgene expression levels relative to a reference formulation after in vitro transfection. However, over the years and among different laboratories, this screening has been...

Full description

Saved in:
Bibliographic Details
Published inJournal of controlled release Vol. 154; no. 3; pp. 218 - 232
Main Authors van Gaal, Ethlinn V.B., van Eijk, Roel, Oosting, Ronald S., Kok, Robbert Jan, Hennink, Wim E., Crommelin, Daan J.A., Mastrobattista, Enrico
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier B.V 25.09.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Screening of new gene delivery candidates regarding transfection efficiency and toxicity is usually performed by reading out transgene expression levels relative to a reference formulation after in vitro transfection. However, over the years and among different laboratories, this screening has been performed in a variety of cell lines, using a variety of conditions and read-out systems, and by comparison to a variety of reference formulations. This makes a direct comparison of results difficult, if not impossible. Reaching a consensus would enable placing new results into context of previous findings and estimate the overall contribution to the improvement of non-viral gene delivery. In this paper we illustrate the sensitivity of transfection outcomes on testing conditions chosen, and propose a screening protocol with the aim of standardization within the field. [Display omitted]
Bibliography:http://dx.doi.org/10.1016/j.jconrel.2011.05.001
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Review-3
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0168-3659
1873-4995
1873-4995
DOI:10.1016/j.jconrel.2011.05.001